Literature DB >> 23349046

Optimizing MRI scan time in the computation of pharmacokinetic parameters (K(trans) ) in breast cancer diagnosis.

Amarnath Jena1, Shashi Bhushan Mehta, Sangeeta Taneja.   

Abstract

PURPOSE: To assess the effects of reduced scan time in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of breast for the evaluation of pharmacokinetic parameters (K(trans) , ve , and kep ).
MATERIALS AND METHODS: High temporal resolution DCE-MRI was performed for calculation of pharmacokinetic parameters (K(trans) , ve , and kep ) at different timepoints using an in-house developed computation scheme adopting the standard model (SM).
RESULTS: The receiver operating characteristic (ROC) curve analysis revealed an area under the ROC curve (AUC) of 0.994 for K(trans) at 90 seconds and 0.987 for K(trans) at 60 seconds with a significant decrease in the AUC for K(trans) at 30 seconds (0.669). While ve showed a consistently higher AUC (>0.9) at timepoints ≥40 seconds, the AUC for kep showed a consistent decline with reduced acquisition times.
CONCLUSION: Reducing the acquisition time for the K(trans) and ve measurement up to 60 seconds yields reasonable accuracy for both and can be incorporated in the routine DCE-MRI protocol for evaluation of enhancing breast lesions.
Copyright © 2013 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  DCE-MRI; Ktrans; acquisition time; pharmacokinetic parameters

Mesh:

Substances:

Year:  2013        PMID: 23349046     DOI: 10.1002/jmri.24008

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  Influence of scan duration on the estimation of pharmacokinetic parameters for breast lesions: a study based on CAIPIRINHA-Dixon-TWIST-VIBE technique.

Authors:  Wen Hao; Bin Zhao; Guangbin Wang; Cuiyan Wang; Hui Liu
Journal:  Eur Radiol       Date:  2014-10-17       Impact factor: 5.315

2.  Feasibility study of dual parametric 2D histogram analysis of breast lesions with dynamic contrast-enhanced and diffusion-weighted MRI.

Authors:  Yanqiong Chen; Bin Wu; Hui Liu; Dan Wang; Yajia Gu
Journal:  J Transl Med       Date:  2018-11-23       Impact factor: 5.531

3.  Dynamic contrast-enhanced MRI versus 18F-FDG PET/CT: Which is better in differentiation between malignant and benign solitary pulmonary nodules?

Authors:  Feng Feng; Fulin Qiang; Aijun Shen; Donghui Shi; Aiyan Fu; Haiming Li; Mingzhu Zhang; Ganlin Xia; Peng Cao
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087

4.  The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.

Authors:  Wei Huang; Yiyi Chen; Andriy Fedorov; Xia Li; Guido H Jajamovich; Dariya I Malyarenko; Madhava P Aryal; Peter S LaViolette; Matthew J Oborski; Finbarr O'Sullivan; Richard G Abramson; Kourosh Jafari-Khouzani; Aneela Afzal; Alina Tudorica; Brendan Moloney; Sandeep N Gupta; Cecilia Besa; Jayashree Kalpathy-Cramer; James M Mountz; Charles M Laymon; Mark Muzi; Kathleen Schmainda; Yue Cao; Thomas L Chenevert; Bachir Taouli; Thomas E Yankeelov; Fiona Fennessy; Xin Li
Journal:  Tomography       Date:  2016-03

5.  Use of Multiple-Tube Phantom: A Method to Globally Correct Native T1 Relaxation Time Inhomogeneity in Dedicated Molecular Magnetic Resonance Breast Coil.

Authors:  Pradeep Singh Negi; Shashi Bhushan Mehta; Amarnath Jena
Journal:  J Med Phys       Date:  2021-05-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.